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In brief
Cox10 encodes a key component of
complex IV in the mitochondrial electron
transport chain. Mah-Som et al. use an
inducible model of Cox10 deletion in type
I ILCs to demonstrate that COX10 is
required for antigen-specific expansion
of NK cells during viral infection but not
cytokine-driven proliferation.
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SUMMARY

Natural killer (NK) cell effector functions are dependent on metabolic regulation of cellular function; however,
less is known about in vivo metabolic pathways required for NK cell antiviral function. Mice with an inducible
NK-specific deletion of Cox10, which encodes a component of electron transport chain complex IV, were
generated to investigate the role of oxidative phosphorylation in NK cells during murine cytomegalovirus
(MCMV) infection. Ncr1-Cox10D/D mice had normal numbers of NK cells but impaired expansion of antigen-specific Ly49H+ NK cells and impaired NK cell memory formation. Proliferation in vitro and homeostatic
expansion were intact, indicating a specific metabolic requirement for antigen-driven proliferation. Cox10deficient NK cells upregulated glycolysis, associated with increased AMP-activated protein kinase (AMPK)
and mammalian target of rapamycin (mTOR) activation, although this was insufficient to protect the host.
These data demonstrate that oxidative metabolism is required for NK cell antiviral responses in vivo.

INTRODUCTION
Natural killer (NK) cells are cytotoxic innate lymphocytes important for the early response to viral infection and malignant transformation. NK cell activation is stimulated through inflammatory
cytokines and activation of germline-encoded activating receptors on their cell surface (Yokoyama, 2013). NK cells are of
increasing translational interest, and they are being used clinically in the context of cancer immunotherapy. There is also the
potential to harness anti-viral properties of NK cells for treatment
of infection and vaccination (Fehniger and Cooper, 2016; Liu
et al., 2020; Myers and Miller, 2021; Sun and Lanier, 2018). While
important triggers of NK cell activation and relevant intracellular
signaling pathways are well understood, less clear are the metabolic regulators of NK cell function, particularly in the context of
viral infection.
Immune cell metabolism and availability of metabolic fuels is
increasingly recognized as essential for immune cell regulation
and function (Buck et al., 2017; Kelly and Pearce, 2020). Oxidative phosphorylation (OXPHOS) and glycolysis, the breakdown
of glucose, are two major metabolic pathways required for generation of energy and building blocks for cellular functions,
including proliferation and expansion of antigen-specific cells.
In immune cells, regulation of these and other metabolic pathways can dictate function, including memory formation and
pro- and anti-inflammatory responses; for example, a switch to

primarily OXPHOS and fatty acid oxidation associated with
memory T cell formation (Buck et al., 2016).
Investigation of NK cell responses to murine cytomegalovirus
(MCMV) has proven to be a useful tool for interrogation of NK cell
anti-viral effectors functions in vivo. In the C57BL/6 genetic
background, approximately 50% of NK cells stochastically express the germline-encoded Ly49H activating receptor, which
recognizes the MCMV-encoded ligand m157. This recognition
strategy allows for a robust NK cell response to infection, and
in the absence of either Ly49H or m157 hosts are highly susceptible to MCMV infection (Arase et al., 2002; Cheng et al., 2008;
Smith et al., 2002). Following infection with MCMV, there is
expansion and contraction of Ly49H-expressing NK cells leading to a pool of innate ‘‘memory’’ cells that have enhanced recall
response to MCMV and other stimuli (O’Sullivan et al., 2015b;
Sun et al., 2009). In humans, a similar population of NK cells
emerges following human CMV (HCMV) infection, frequently
associated with the germline-encoded NKG2C activating receptor that can recognize HCMV peptides (Hammer et al., 2018).
These human adaptive NK cells have enhanced function, particularly when triggered by antibodies, and they also expand and
respond to other infections (Fehniger and Cooper, 2016).
Previous studies have suggested that metabolism is important
for NK function during MCMV infection. For example, inhibition
of mammalian target of rapamycin (mTOR), a regulator of metabolism, impairs multiple NK cell functions during MCMV infection
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in vivo (Donnelly et al., 2014; Nandagopal et al., 2014), while genetic deletion of mTOR inhibits NK cell differentiation (Marçais
et al., 2014). Administration of glucose metabolism inhibitor during MCMV infection inhibited NK cell killing and led to susceptibility to infection (Mah et al., 2017). Previous in vitro work demonstrated that murine NK cells primarily use glucose-driven
OXPHOS at rest (Keating et al., 2016; Keppel et al., 2015), and
both murine and human NK cells require OXPHOS to produce
the cytokine interferon (IFN)-g in response to certain stimuli
(Keating et al., 2016; Keppel et al., 2015).
To investigate the effects of oxidative metabolism on NK cell
function, we generated mice with tamoxifen-inducible NK-specific deletion of Cox10 (Ncr1-Cox10D/D). The Cox10 gene encodes a farnesyltransferase involved in the synthesis of heme
a, part of the catalytic core of cytochrome c oxidase (COX).
COX, also known as complex IV, is a key component of the mitochondrial electron transport chain (ETC) and is a rate-limiting
step of OXPHOS (Diaz, 2010). Defects in complex IV, including
Cox10 deficiency, result in mitochondrial disease in humans (Antonicka et al., 2003; Valnot et al., 2000). Pediatric patients with
mitochondrial disease have increased susceptibility to infection,
in particular respiratory viral infections (Tarasenko et al., 2017).
Cox10 was required for maximal T cell proliferation during viral
infection in a mouse model of T cell-specific deletion of Cox10
(Tarasenko et al., 2017). These clinical observations suggest
that defects in oxidative metabolism may alter the immune
response to pathogens.
Antiviral responses of mice with NK-specific Cox10 deficiency
were investigated during MCMV infection. Cox10-deficient NK
cells developed normally, and in vitro functions are largely intact;
however, we observed an NK cell-intrinsic impaired expansion of
Ly49H+ MCMV-specific NK cells lacking Cox10.
RESULTS
Inducible NK cell-specific deletion of Cox10
An NK cell and ILC1-specific inducible model of Cox10 deletion,
Ncr1-Cox10D/D, was generated by crossing mice with tamox-

OPEN ACCESS

ifen-inducible iCre recombinase driven by Ncr1 (Ncr1-iCreERT2)
(Wagner et al., 2020) with mice carrying loxP sites flanking exon 6
of Cox10 (Diaz et al., 2005) and yellow fluorescent protein (YFP)
Cre-reporter mice. Ncr1 encodes the cell surface receptor
NKp46 and was chosen, as its expression early during NK cell
development defines a murine NK cell compared to an NK precursor. Control mice with tamoxifen-inducible Ncr1-driven Cre
and the same YFP reporter were used as controls (Ncr1-wildtype [WT]). For all flow cytometry-based experiments, NK cells
from Ncr1-Cox10D/D and Ncr1-WT mice were gated on YFP+
NK cells to identify cells with Cre-recombinase activity (Figure 1A
and representative flow gating in Figure S1). Following 2 days of
tamoxifen chow, Cre activity was observed in 60%–80% of NK
cells based on YFP expression (Figure 1A). Cox10 transcript
was undetectable 3 days after induction in YFP-positive cells
from Ncr1-Cox10D/D mice (Figure 1B). YFP-negative cells also
had lower expression of Cox10 transcript, suggesting that there
may have been Cre-mediated excision in some cells that had not
yet expressed YFP protein.
NK cells from Ncr1-Cox10D/D and Ncr1-WT mice were present
in similar numbers in the spleen, bone marrow, and liver at days 3
and 7 after Cre induction (Figure 1C). However, total numbers of
NK cells were increased in the bone marrow of Ncr1-Cox10D/D
mice at day 7 (Figure 1C), suggesting increased production of
Cox10-sufficient NK cells at this time point. Maturation of
Cox10-deficient NK cells measured by CD11b and CD27 (Chiossone et al., 2009) demonstrated the presence of mature stage 4
(CD11b+CD27) and intermediate stage 3 (CD11b+CD27+) and
stage 2 (CD11bCD27+) populations, but no stage 1 immature
(CD27CD11b) cells. There were no differences in maturation
stage of Cox10-deficient or WT NK cells, with the exception of
increased stage 4 cells in the liver at day 7 (Figure 1D). Expression
of common activating and inhibitory receptors, including Ly49H
(Figure 1E), Ly49C/I, NKG2A/C/E, and NKG2D (data not shown),
was also similar. To test cytotoxic capacity, degranulation was
measured in response to YAC-1 tumor targets, and it was similar
between Cox10-deficient and WT NK cells (Figure 1F). Killing of
YAC targets was also intact in Cox10-deficient NK cells

Figure 1. Phenotype of NK cells in inducible Ncr1-Cox10D/D mice
(A) Mice were fed tamoxifen-containing chow for 2 days and then analyzed after 3 or 7 days. Representative flow of Cre induction by the YFP reporter (day 3) is
shown.
(B) Cox10 transcript (day 3), normalized to YFP cells from Ncr1-Cox10D/D mice (Mann-Whitney test, n = 2–5 mice/group, two independent experiments, error
bars represent SEM).
(C) Absolute numbers of YFP+ NK cells in the spleen, bone marrow (BM), and liver (two-way ANOVA, n = 8 mice/group, three independent experiments, pooled
data shown, error bars represent SD).
(D) NK maturation of YFP+ cells by CD11b and CD27; stage 2 = CD27+CD11b, stage 3 = CD27+CD11b+, stage 4 = CD27-CD11b+ (two-way ANOVA, n = 8 mice/
group, three independent experiments with all p > 0.1000, except as shown, error bars represent SD).
(E) Normal expression of Ly49H (day 3, n = 4 mice/group, paired t test, error bars represent SEM).
(F) Degranulation of NK cells (CD107a) was similar (n = 9–10 mice/group, three independent experiments, two-way ANOVA, error bars represent SD).
(G) Killing of YAC-1 targets demonstrates similar cytotoxic capacity (day 3, n = 3 mice/group, two-way ANOVA, one experiment shown representative of three
independent experiments, error bars represent SD).
(H) Percentage of IFN-g+ NK cells following stimulation with cytokines (IL12+IL-15 or IL-12+IL-18) or activating receptors (anti-Ly49H, anti-Ly49H+IL-15, and antiNK1.1) (mixed effects analysis with Sidak’s multiple comparisons test, n = 5–6 mice/group, two independent experiments, pooled data shown, error bars
represent SD).
(I–M) Extracellular flux assay of YFP+ NK cells cultured with IL-2.
(I and J) Oxygen consumption rate (OCR; I) and OCR/ECAR (extracellular acidification rate) ratio (J) during Mito Stress test (Agilent Technologies).
(K) Cox10-deficient NK cells had a lower baseline OCR and higher ECAR, with a decreased OCR/ECAR ratio.
(L and M) Spare respiratory capacity (SRC; L) and maximal OCR (M) after carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP) were similar (n = 3-5
technical replicates using n = 5–8 pooled mice, unpaired Student’s t test, error bars show SEM).
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(Figure 1G). Cells from both models produced similar IFN-g in
response to cytokine (interleukin [IL]-12+IL-15, IL-12+IL-18) and
receptor (anti-Ly49H or anti-NK1.1) stimulation (Figure 1H). These
findings demonstrate that deletion of Cox10 in NK cells at a time
when the Ncr1 gene is expressed does not alter NK cell maturation or ex vivo cytokine and cytotoxic function.
Extracellular flux assays were performed on purified YFP+
cells cultured with IL-2 for 3 days, and they identified a baseline
decreased oxygen consumption rate (OCR) with a higher rate of
aerobic glycolysis (extracellular acidification rate [ECAR]) and
lower OCR/ECAR ratio (Figures 1I–1K) in Cox10-deficient NK
cells. However, their ability to upregulate OXPHOS (spare respiratory capacity [SRC]) remained intact (Figure 1L), and maximal
OCR rates were not significantly different compared to WT (Figure 1M). A COX activity assay demonstrated decreased activity
in NK cells purified from Ncr1-Cox10D/D mice compared to WT
mice (Figure S1C). Overall, these findings demonstrate that
Cox10-deficient NK cells have impaired complex IV activity
and following IL-2 activation have decreased baseline OXHOS
and increased glycolysis.
Mice with constitutive Ncr-1-driven Cre were also generated,
and they showed percentages and numbers of NK cells similar
to controls in different organs (Figures S2A and S2B) with normal
maturation (Figure S2C) and expression of NK receptors (Figure S2D). Similar to inducible Ncr1 deletion, NK cells from the
constitutive model also had intact IFN-g production (Figure S3A).
Taken together, these findings suggest that acute deletion of
Cox10 in NK cells at the time of Ncr1 expression does not significantly alter NK cell maturation, activation, IFN-g production, or
target killing at baseline. Inducible deletion of Cox10 results in
an increased baseline glycolytic rate, potentially as a compensatory mechanism for loss of this gene encoding an important
component of complex IV.
Defect in Cox10-deficient NK cell antigen-induced
proliferation
Infection of C57BL/6 mice with MCMV leads to well-characterized NK cell responses, including expansion of cells expressing
the activating receptor Ly49H, which recognizes the MCMV-en-

OPEN ACCESS

coded ligand m157 (Yokoyama, 2013). To determine whether
Cox10 was important for this antiviral function of NK cells,
mice were infected with MCMV (Figure 2A). At day 4, the peak
time for proliferation of Ly49H+ NK cells (Dokun et al., 2001),
Ncr1-Cox10D/D mice had significantly fewer splenic Ly49H+ NK
cells than did control mice (Figure 2A). Similar observations
were made in mice with constitutive Ncr1-Cre driving Cox10
deficiency (Figures S3B and S3C), suggesting that the effect
on proliferation was not due to the abrupt deletion of Cox10 in
NK cells that developed with intact OXPHOS. Analysis of NK
cells at an earlier time point in the constitutive model also
demonstrated intact IFN-g production following MCMV infection
(Figure S3D), an important NK cell function during the first 1–
2 days of infection driven by inflammatory cytokines.
Both Cox10-deficient and WT NK cells displayed preferential
proliferation of splenic Ly49H+ cells, measured by 5-bromo-20 deoxyuridine (BrdU) incorporation into replicating DNA (Figure 2B). However, significantly fewer Cox10-deficient Ly49H+
NK cells from Ncr1-Cox10D/D mice (YFP+Ly49H+) proliferated
compared to WT-YFP+ cells. There was no defect in proliferation
of YFP-negative cells from Ncr1-Cox10D/D mice (Figure 2B,
YFP), further supporting a specific role for Cox10 deletion.
This proliferative defect in splenic NK cells was associated
with impaired viral control at that site, as evidenced by increased
MCMV copy number in the spleen (Figure 2C). There were no differences in MCMV copy number in the liver, suggesting that
there may be local differences in viral control. Interestingly,
ILC1s, the other major population affected by Cox10 deletion
in this Ncr1-driven system, had normal proliferation measured
by BrdU incorporation (Figure S4), suggesting differences in
metabolic regulation of innate lymphocyte proliferation.
To determine whether defects in NK cell proliferation were specific to viral infection, the proliferative capacity of Cox10-deficient
NK cells to other stimuli was tested. Stimulation with IL-15 demonstrated normal proliferation by Cox10-deficient NK cells in vitro
(Figure 2D; Figure S3E). To test NK cell proliferation in vivo, NK
cells were transferred into Rag2/gc/ mice to examine homeostatic proliferation, a process driven largely by cytokines (Prlic
et al., 2003). Congenically marked splenic Ncr1-Cox10D/D and

Figure 2. Cox10-deficient NK cells have impaired proliferation in response to activating ligand stimulation during MCMV infection

(A–C) Female Ncr1-Cox10D/D and Ncr1-WT mice were infected with 5 3 104 plaque-forming units (PFU) of MCMV and analyzed at day 4.
(A) The percentage and number of YFP+Ly49H+ NK cells were significantly lower in Ncr1-Cox10D/D mice.
(B) BrdU incorporation was lower in Ly49H+ NK cells lacking Cox10 (YFP+ Ly49H cells from Ncr1-Cox10D/D mice), demonstrating a defect in proliferation in
antigen-specific NK cells.
(C) MCMV copy number normalized to b-actin was higher in Ncr1-Cox10D/D mice.
Data in (A)–(C) represent four separate experiments (individual mice are shown), analyzed using an unpaired t test for (A), a two-way ANOVA for (B), and an
unpaired t test of log-transformed data for (C).
(D) NK cell proliferation following 3 days of IL-15 culture. Representative CTV histograms are shown for WT (blue) or Cox10-deficient (green) NK cells with lowdose IL-15 (LD, 5–10 ng/mL) or high-dose IL-15 (HD, 100 ng/mL). The percentage of proliferated cells was the same between the LD and HD groups. The
proliferation index was the same between WT and Cox10-deficient cells and was higher with HD IL-15 compared to LD IL-15 (n = 6–14/group in four independent
experiments, pooled data shown, two-way ANOVA).
(E) WT and Cox10-deficient NK cells were co-transferred into Rag2/gc/ host mice, with similar ratios of cells recovered. (n = 2 hosts/group in three independent experiments, pooled data analyzed by two-way ANOVA).
(F) Ncr1-Cox10D/D and Ncr1-WT splenocytes cultured with IL-15 for 2 days followed by addition of Ba/F3-m157 cells for 3 days. Representative flow histograms
of CTV for Ly49H+ and Ly49H NK cells (all YFP+) are shown.
(G–I) There was no difference in percentage of cells that divided (G), but proliferation analysis demonstrated significantly reduced (H) proliferation index and (I)
replication index in Ly49H+ Cox10-deficient NK cells compared to WT (two-way ANOVA, n = 13 mice/group in five independent experiments).
(J) Annexin V staining was similar, representative flow plots with WT on the left and Cox10-deficient on the right and pooled data shown (two-way ANOVA, n = 7–9
mice/group, three independent experiments). For all experiments, error bars represent mean and SD.

Cell Reports 35, 109209, June 1, 2021 5

ll
OPEN ACCESS

Report

A

B

C

D

Figure 3. Single-cell RNA-seq and evaluation of mTOR and AMPK activation in NK cells during MCMV infection
(A and B) Ncr1-Cox10D/D and Ncr1-WT NK cells were examined by single-cell sequencing 4 days after MCMV infection with uninfected controls.
(A) UMAP clustering of expression data using 20 principal components. Clusters 8 and 9 were expanded in response to MCMV infection in both groups, but
cluster 10 was primarily expanded only with Cox10-deficient infected mice, accounting for 20% of NK cells.
(B) Dot plot showing percentage of cells per sample expressing gene of interest (size) and average expression of gene (color) of transcriptionally regulated
glycolytic genes upregulated during MCMV infection.
(C and D) NK cells from Ncr1-Cox10D/D and Ncr1-WT mice 4 days after MCMV expressing phosphorylated (C) mTOR and (D) AMPK in Ly49H and Ly49H+
populations (mixed effects model with Tukey’s multiple comparison test, three independent experiments, n = 10–12 mice/group, pooled data, error bars
represent SD). pAMPK was upregulated specifically in Ly49H+ Cox10-deficient NK cells.

Ncr1-WT cells were co-transferred at similar ratios into Rag2/
 /
gc
hosts, and analysis of spleens at days 3 and 5 showed
similar percentages of each population (Figure 3E).
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These findings suggested that the proliferative defect seen
in vivo was due to Ly49H stimulation. To investigate this, we
used an in vitro system to simulate both cytokine and Ly49H
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stimulation (Figure 3F) to model stimuli seen during MCMV, since
early NK cell activation is driven by cytokines followed by antigenspecific Ly49H stimulation (Dokun et al., 2001). Splenocytes from
Ncr1-Cox10D/D and Ncr1-WT mice were labeled with CellTrace Violet (CTV) and cultured in 20 ng/mL IL-15 for 2 days, followed by
addition of m157-expressing Ba/F3 cells. There was preferential
expansion of Ly49H+ NK cells (Figure 2F, histograms). While the
absolute percentage of Ly49H and Ly49H+ NK cells that divided
was the same (Figure 2G), the total number of divisions (proliferative index, Figure 2H) and fold expansion (replication index, Figure 2I) of dividing cells was significantly higher in Ly49H+ cells in
both Cox10-deficient and WT mice, similar to that seen with
Ly49H-specific proliferation during MCMV. Cox10-deficient
Ly49H+ NK cells had an overall decreased proliferation compared
to WT Ly49H+ cells, based on proliferation and the replication index of dividing cells (Figures 2H and 2I). Annexin V staining of cells
to measure apoptosis did not show any differences, suggesting
that the defect observed with Ly49H stimulation is proliferative
and not induction of apoptosis (Figure 2J).
These results suggest that Cox10-deficient NK cells have a
specific defect in activation receptor-induced proliferation, and
that this effect is likely amplified in vivo in the context of viral
infection.
Single-cell RNA sequencing identifies viral-specific NK
cells
To investigate possible mechanisms behind this defect in virusdriven proliferation, single cell RNA-sequencing (scRNA-seq)
was performed on YFP+ NK cells from Ncr1-Cox10D/D and
Ncr1-WT mice 4 days after MCMV infection and compared to uninfected cells. Both Ncr1-Cox10D/D and Ncr1-WT NK cells
demonstrated a strong MCMV-induced transcriptional signature
with differential expression of >500 genes that was generally
similar between the two groups (Figure S5A). Analysis by UMAP
clustering identified two clusters of cells (clusters 8 and 9) that
were expanded with MCMV infection in both WT and Cox10-deficient mice (Figure 3A). These clusters consisted largely of Ly49H+
cells (Figure S5B). There was also a distinct population (cluster 10)
present primarily in Cox10-deficient MCMV-infected NK cells that
accounted for 19% of cells in those cells (Figure 3A). Cluster 10
was comprised mostly of Ly49H+ cells largely negative for the
NK transcription factors Eomes and T-bet (Figure S5B). Among
the most highly upregulated genes in this cluster were Spp1,
Gzmb, and Ly6a, all of which are known to increase in NK cells
during MCMV infection (Fogel et al., 2013; Leavenworth et al.,
2015). The presence of granzyme B transcript, which encodes a
major protein in NK cell cytotoxic granules, supports that these
are bona fide cytotoxic NK cells and not ILC1 cells, which express
some NK cell receptors but do not produce cytotoxic granules
(Figure S5C). No major differences in pro- or anti-apoptotic
gene expression were seen in this cluster (Figures S6A and
6SB). Rather, cells in cluster 10 were best classified as in the
G2/M (mitotic) phase of the cell cycle based on transcriptional
analysis (Figure S6C). However, many genes responsible for triggering mitosis (Shen et al., 2018), including cyclin B (Ccnb), Cdk1,
and Cdc25c, were expressed by few cells and at lower levels in
this cluster (Figure S6D), suggesting that these NK cells may be
in G2 arrest. By comparison, cells in cluster 9, also in the G2/M
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phase, had upregulated expression of these genes, suggesting
active cycling (Figure S6D). Consistent with cell cycle arrest, the
most transcriptionally downregulated processes were mitosis
and DNA synthesis/repair (Figure S6E). Overall, the signature of
cluster 10 suggests that this population was responding to
MCMV but may be experiencing cell cycle arrest at the G2/M
checkpoint due to Cox10 deficiency, suggesting a mechanism
whereby Cox10-deficient Ly49H+ NK cells fail to expand appropriately during MCMV infection.
Cox10 deficiency leads to upregulation of mTOR and
AMP-activated protein kinase (AMPK) activation in NK
cells
Focusing on metabolic genes revealed that MCMV infection led
to upregulation of transcriptionally regulated glycolytic genes
(Ldha, Gapdh, Pkm, Eno1, Pgk1, and Aldoa) with infection, which
was increased in Cox10-deficient cells (Figure 3B). Two major
regulators of glycolysis in immune cells are mTOR and AMPK.
We hypothesized that either of these pathways may be associated with increased glycolysis in cells. Generally, mTOR is downregulated by AMPK; however, Cox10-deficient NK cells had
increased expression of phosphorylated mTOR (pmTOR) and
AMPK (pAMPK) compared to WT during MCMV infection (Figures 3C and 3D). Increased pmTOR and pAMPK was seen in
both Ly49H-negative and -positive Cox10-deficient NK cells,
suggesting it was not limited to the Ly49H compartment. However, pAMPK was significantly higher in Ly49H+ cells from
Cox10-deficient NK cells and not WT cells, suggesting that the
compensatory increase in pmTOR with Cox10 deficiency was
not sufficient for the metabolic stress in those cells.
NK cells lacking Cox10 do not expand as required for
induction of an MCMV memory population
Expansion of Ly49H+ NK cells during MCMV infection leads to
the induction of a group of cells with adaptive features, including
increased effector functions in the context of subsequent MCMV
infection (Sun et al., 2009). The expansion and contraction of
these cells are required for formation of such MCMV memory
NK cells (Adams et al., 2020). Based on impaired proliferation
of Ly49H+ cells we hypothesized that formation of such memory
would be defective. Indeed, a switch from glycolysis to OXPHOS
is associated with T cell memory formation (Geltink et al., 2018).
The potential for expansion of NK cells, and thus the potential to
form memory, can be directly measured in a competitive transfer
system in which the input cells are the only ones expressing
Ly49H (O’Sullivan et al., 2015a; Sun et al., 2009). To determine
the intrinsic effects of Cox10 deficiency on expansion capacity,
we adoptively transferred YFP+ cells from Ncr1-Cox10D/D
(Ly5.2+) and Ncr1-WT (Ly5.1+) into the same Ly49H-deficient
host (B6.BXD8) followed by infection with MCMV (Figure 4A).
This transfer model also addresses confounding factors, for
example if Cox10 deficiency changed the cytokine milieu or viral
titer. YFP+ NK cells from Ncr1-Cox10D/D (Ly5.2+) and Ncr1-WT
(Ly5.1+) mice were co-transferred at similar ratios into Ly49Hdeficient hosts (B6.BXD8) followed by MCMV infection (Figure 4A). NK cell numbers in the blood were measured by serial
bleeds of animals. The peak numbers of Ly49H+ NK cells occur
at day 7 post-infection, after which they contract to form a
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Figure 4. Cox10 deficiency impairs MCMV-induced expansion required for memory formation

(A) Congenic Ncr1-WT and Ncr1-Cox10D/D mice NK cells were co-transferred at a similar ratio into Ly49H-deficient hosts, and infected with MCMV. The proportion of each cell type was tracked in the blood weekly and in the spleen at day 28.
(B) Percentage of transferred Ly49H+ cells present among all NK cells in the host.
(C) Ratio of WT to Cox10-deficient NK cells in the blood and spleen (two-way ANOVA for blood, and one-way ANOVA for the spleen, ***p < 0.0001).
(D) Absolute number of transferred NK cells in the spleen at day 28 (two-way ANOVA). Pooled data are from three separate experiments; n = 11 recipient infected,
4 uninfected mice, error bars represent SD.

memory population (Sun et al., 2009). After 7 days, there were
very few detectable Cox10-deficient NK cells, while there was
robust expansion and contraction of WT Ly49H+ NK cells as
measured by the percentage of NK cells that were Ly49H+ in
both inducible and constitutive models (Figure 4B; Figures S3F
and S3G). NK cells contracted over 28 days, and at all time
points there were significantly more WT than Cox10-deficient
NK cells, measured as the percentage of all NK cells that were
Ly49H+ (Figure 4B) or by comparing the percentage of donor
cells that were Cox10-deficient or WT (Figure 4C). At day 28,
the absolute numbers of cells present in the spleen were similar
to those in uninfected hosts, while only WT NK cells expanded
following MCMV infection (Figure 4D). These experiments
demonstrate an NK-intrinsic defect in MCMV-driven expansion
of Ly49H+ NK cell required for memory formation.
DISCUSSION
In this study, we demonstrate that Cox10, a gene encoding a
component of electron transport chain complex IV of the mitochondrial electron transport chain, is required for NK cell antigen-specific expansion and control of MCMV infection in both
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inducible and constitutive NK-specific genetic models. Interestingly, acute or chronic deletion of Cox10 in mature NK cells with
the inducible or constitutive Cre models did not significantly alter
NK phenotype, homeostasis, cytotoxic function, or cytokine production. This somewhat surprising finding demonstrates that
robust OXPHOS is not required for NK cell development, at least
after the stage at which NKp46 (Ncr1) is expressed. However,
during MCMV infection, there was a clear requirement for
Cox10 for expansion of Ly49H+ NK cells, a requisite step for generation of NK cell memory. This effect was cell-intrinsic, as
demonstrated by co-transfer experiments. Impaired antigenspecific proliferation could be recapitulated in vitro in the presence of cytokine followed by co-culture with antigen-bearing
target cells; however, proliferation in response to cytokines alone
or homeostatic proliferation in vivo was normal. The fact that
in vitro function for the most part was normal, while in vivo
effector function (proliferation) was impaired, also highlights
the challenges in re-capitulating metabolic microenvironments
in vitro and the need to study immune cell metabolism in vivo.
NK cells primarily rely on OXPHOS for energy generation and
IFN-g production downstream of activating receptor stimulation
at baseline (Keppel et al., 2015; Marçais et al., 2014). Following
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prolonged cytokine activation, NK cells upregulate glycolysis
and OXPHOS (O’Brien and Finlay, 2019). A genetic model of disrupted Srepb signaling and the citrate-malate shuttle led to
impaired OXPHOS and glycolysis, with defects in NK cell proliferation in response to cytokines (Assmann et al., 2017). In the
present study, Cox10 deficiency partially impaired OXPHOS
with increased glycolysis with IL-2 stimulation or MCMV infection. However, Cox10-deficient NK cells had normal proliferation
in response to IL-15 and homeostatic proliferation, which is
largely driven by cytokines. This highlights metabolic flexibility
in NK cells and distinct requirements for different effector functions depending on the context in which NK cells are activated.
Deficiency of Cox10 led to increased activation of both mTOR
and AMPK during MCMV infection. mTOR is important for NK
cell maturation and function, in part through upregulation of
glycolysis (Donnelly et al., 2014; Marçais et al., 2014; Nandagopal et al., 2014). Deficiencies in complex IV activate AMPK, a major energy sensor in cells (Kogot-Levin et al., 2016), and AMPK is
phosphorylated in response to energetic stress to increase production of ATP by upregulating glycolysis and oxidative metabolism (Garcia and Shaw, 2017). Increased phosphorylation of
mTOR in Cox10-deficient NK cells was not dependent on antigen-specific responses, and it was similarly increased in both
Ly49H+ and Ly49H- Cox10-deficient NK cells. We hypothesize
that this is due to the energetic stress of infection, including cytokines associated with infection, and is consistent with the
known role of mTOR in upregulating glycolysis in NK cells (Donnelly et al., 2014; Marçais et al., 2014). While mTOR generally inhibits AMPK activation, there was significantly more pAMPK in
antigen-specific, Ly49H+, Cox10-deficient NK cells as compared
to Ly49H- cells, suggesting an effect of activating receptor
engagement here. AMPK is a critical sensor for low energy
(AMP/ATP ratio) and responds by activating catabolic processes, including glycolysis and fatty acid oxidation, while inhibiting protein and macromolecule synthesis (Garcia and Shaw,
2017), thus preserving cellular fitness at the expense of cellular
replication. Thus, a possible explanation for activation of both
mTOR and AMPK is the need to upregulate glycolysis to ensure
cell survival during infection. AMPK has also been shown to
cause G2 arrest (Shen et al., 2018). We hypothesize that in the
setting of MCMV infection, Cox10 deficiency leads to activation
of AMPK and subsequent G2 arrest, as suggested by scRNA-seq
data, with dampening of antigen-specific NK cell expansion.
Interestingly, upregulation of AMPK at the peak of NK cell
expansion has been shown to promote NK cell memory formation
during MCMV infection through induction of autophagy (O’Sullivan et al., 2015a). Here, Cox10 deficiency was associated with upregulated phosphorylation of AMPK in antigen-specific Ly49H+
cells 4 days after infection. Failed expansion of Cox10-deficient
NK cells following MCMV infection in a competitive transfer model
supports the lack of induction of memory response due to Cox10
deficiency (Sun et al., 2009). These seemingly contrasting findings
highlight the importance of the timing of metabolic changes. In the
present study, failure to induce the initial expansion of antigenspecific cells was associated with upregulation of AMPK, whereas
O’Sullivan et al. (2015a) demonstrated that activation of AMPK
during the contraction phase of NK cells, after peak expansion,
is important for memory formation.

Work by Sheppard et al. (2021, this issue of Cell Reports) using
a genetic model of NK-specific lactate dehydrogenase A (Ldha)
deficiency suggests that limiting fermentation and aerobic
glycolysis impairs NK cells and also impairs proliferative capacity and memory formation, as well as cytotoxicity. Interestingly,
these NK Ldha-deficient mice also had normal numbers and
phenotype of NK cells at baseline, and the requirement for
glycolysis only became apparent when the NK cells encountered
challenges, viral infection, and tumor (Sheppard et al., 2021). We
observed increased Ldha expression associated with an
increased glycolytic signature in Cox10-deficient NK cells; however, this was not sufficient to allow for normal proliferation and
host viral control. This supports that both aerobic glycolysis and
OXPHOS must be intact for normal NK cell responses to MCMV.
Collectively, these studies of genetic manipulation of OXPHOS
and glycolysis in NK cells demonstrate that while some NK cell
functions have metabolic flexibility, for example development
and response to cytokines, antigen-driven proliferation during
viral infection has absolute metabolic requirements for both
glycolysis and OXPHOS.
In summary, deficiency in the mitochondrial respiratory chain
gene Cox10 led to impaired antigen-specific expansion of NK
cells during MCMV infection. This model also demonstrates
that NK cells have metabolic flexibility that can compensate for
defects in OXPHOS, but that these mechanisms fail during antigen-driven proliferation in vitro and in vivo. NK cells are important
for host control of viruses and tumors, and identification of relevant metabolic pathways for their function in these contexts is
important for considering therapeutic approaches targeting NK
cells, as well as for a better understanding of the immune
response in patients with metabolic defects.
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Antibodies
Alexa-647 rat anti-mouse NKp46 (clone 29A1.4)

BD Biosciences

Cat# 560755; RRID:AB_1727464

APC mouse anti-mouse NK1.1 (clone PK136)

BD Biosciences

Cat#550627; RRID:AB_398463

APC/Cyanine7 anti-mouse CD19 (clone 6D5)

Biolegend

Cat# 115530; RRID:AB_830707

APC-Cy7 Hamster Anti-Mouse CD11c (Clone HL3)

BD Biosciences

Cat# 561241; RRID:AB_10611727

APC-Cy7 hamster anti-mouse CD3epsilon (clone
145-2C11)

Biolegend

Cat# 100330; RRID:AB_1877170

BV421 hamster anti-mouse CD3epsilon (clone
145-2C11)

Biolegend

Cat# 100336; RRID:AB_11203705

BV421 mouse anti-mouse CD45.1 (clone A20)

BioLegend

Cat#110732; RRID:AB_2562563

BV421 mouse anti-mouse NK1.1 (clone PK136)

BD Biosciences

Cat# 562921; RRID:AB_2728688

BV421 rat anti-mouse Ly49H (clone 3D10)

BD Biosciences

744260; RRID:AB_2742099

BV421 hamster anti-mouse CD49a (clone Ha31/8)

BD Biosciences

Cat# 740046; RRID:AB_2739815

BV605 NKG2A/C/E (clone 20d5)

BD Biosciences

Cat#564382; RRID:AB_2738782

Mouse anti-mouse Ly49C+I (clone 5e6)

BD Biosciences

Cat#553277; RRID:AB_394751

PE goat anti-rabbit F(ab’)2 (polyclonal)

Cell Signaling Technologies

Cat# 8885; RRID:AB_2797677

PE hamster anti-mouse CD3epsilon (clone
145-2C11)

Biolegend

Cat# 100308; RRID:AB_312673

PE mouse anti-mouse BRDU (clone 3D4)

BD Biosciences

Cat# 556029; RRID:AB_396305

PE mouse anti-mouse phospho-MTOR (clone
MRBBY)

ThermoFisher

Cat# 12-9718-42; RRID:AB_2572724

PE rat anti-mouse (clone XMG1.2)

BioLegend

Cat#505808; RRID:AB_315402

PE rat anti-mouse CD107a (clone 1D4B)

BD Biosciences

Cat# 558661; RRID:AB_1645247

PE rat anti-mouse CD11b (clone M1/70)

BD Biosciences

Cat#557397; RRID:AB_396680

PE rat anti-mouse Ly49H (clone 3D10)

BioLegend

Cat#144705; RRID AB_2561673

PE Annexin V (Ca2+ dependent phospholipidbinding protein)

BD Biosciences

Cat# 556421; RRID:AB_2869071

PE-Cy7 hamster anti-mouse CD27 (clone LG.3A10)

BD Biosciences

Cat#563604; RRID:AB_2738309

PE-Cy7 mouse anti-mouse CD45.1 (clone A20)

BioLegend

Cat# 110730; RRID:AB_1134168

PE-Cy7 rat anti-mouse Ly49H (clone 3D10)

Biolegend

144714; RRID:AB_2783113

PE-Cy7 rat anti-mouse CD127 (clone A7R34)

Biolegend

Cat# 135014; RRID:AB_1937265

PerCP/Cyanine5.5 anti-mouse DX5 (clone CD49b)

Biolegend

Cat# 108916; RRID:AB_2129358

PerCP-Cy5.5 hamster anti-mouse CD3epsilon
(clone 145-2C11)

Biolegend

Cat# 100328; RRID:AB_893318

Rat anti mouse CD226/DNAM-1 (clone 10E5)

BioLegend

Cat#128806; RRID:AB_1186119

Rat anti-mouse NKG2D (clone CX5)

BioLegend

Cat# 130212; RRID:AB_1236372

Unconjugated mouse anti-mouse NK1.1 (PK136)

BioXcell

Cat# BE0036; RRID:AB_1107737

Unconjugated rabbit anti-human phospho-AMPKalpha (clone 40H9)

Cell Signaling Technologies

Cat# 2535; RRID:AB_331250

Unconjugated rat anti-mouse CD16 (clone 2.4g2)

ATCC

ATCC Cat# HB-197; RRID:CVCL_9148

Unconjugated anti-mouse Ly49H (clone 3D10)

Biolegend

Cat# 144702; RRID:AB_2561549

ATCC

Cat#ATCC VR-1399

7-AAD (7-Amino Actinomycin D)

Millipore-Sigma

Cat# 129935

BD Cytofix/cytoperm

BD Biosciences

Cat# 554714

Bacterial and virus strains
Murine cytomegalovirus (MCMV)
Chemicals, peptides, and recombinant proteins
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BrdU

MilliporeSigma

Cat# B5002

Brefeldin A

BD Biosciences

Cat# 555029

Draq5

Cell Signaling

Cat# 4084S

GolgiStop (monensin)

BD Biosciences

Cat #: 554724

Mouse recombinant IL-12

PeproTech

Cat# 210-12

Mouse recombinant IL-15

Stem Cell

Cat# 78080.1

Mouse recombinant IL-18

MBL

Cat#B002-5

Tag-it Violet

BioLegend

Cat# 425101

Tamoxifen Chow

Envigo

Cat# TD.130856

Zombie Yellow

Biolegend

Cat# 423104

Critical commercial assays
ATPLite Luminescence Assay

Perkin Elmer

Cat# 6016941

BrdU Assay

BD Biosciences

Cat# 552598

COX assay

MilliporeSigma

Cat# CYTOCOX1

cytochrome c

MilliporeSigma

Cat #: C3131

Dithiothreitol (DTT)

MilliporeSigma

Cat #: D0632

Gentra Puregene Tissue Kit

QIAGEN

Cat# 158667

Mouse NK cell Enrichment (EasySep)

StemCell

Cat# 19855

N-dodecyl-B-D-Maltoside

MilliporeSigma

Cat #: D4641

RNA Easy kit

QIAGEN

Cat# 74104

Seahorse XF Cell Mito Stress Test Kit

Agilent

Cat #: 103015-100

This paper

GSE149659

Deposited data
Single cell RNA sequencing raw data
Experimental models: Cell lines
YAC1

ATCC

ATCC TIB-160; RRID CVCL_2244

Ba/F3-m157 cells

W. Yokoyama

Smith et al., 2002

Mouse: Cox10D/D; B6.129X1-Cox10tm1Ctm/J

The Jackson Laboratory

Cat# 024697; RRID IMSR_JAX:024697

Mouse: YFP reporter; B6.129X1-Gt(ROSA)
26Sortm1(EFYP)Cos/J

The Jackson Laboratory

Cat# 006148; RRID IMSR_JAX:006148

Experimental Models: Organisms/Strains

Mouse: B6.Bxd8; B6.BXD8-Klra8Cmv1-del/WumJ

The Jackson Laboratory

Cat# 008633; RRID IMSR_JAX:008633

Mouse: Rag2/gc/; B10;B6-Rag2tm1Fwa
Il2rgtm1Wjl

Taconic

Cat# 4111; RRID IMSR_TAC:4111

Mouse: cNcr1; Tg(Ncr1-icre)265Sxl

Eckelhart et al., 2011

MGI ID: 4941472

Mouse: Ly5.1; B6.SJL-PtprcaPepcb/BoyCrCrl

Charles River

Cat# 564, RRID IMSR_CRL:564

Mouse: Ncr1-iCreERT2

Wagner et al., 2020

N/A

Beta actin primer/probe set

Thermofisher

Cat# 4352341E

COX10 primer/probe set

Thermofisher

Cat# Mm00617695_m1

MCMV (IE1) primer/probe set Primer 1
CCCTCTCCTAACTCTCCCTTT

IDT Custom PrimeTime Probe
Parikh et al., 2015

N/A

MCMV (IE1) primer/probe set Primer 2
TGGTGCTCTTTTCCCGTG

IDT Custom PrimeTime Probe
Parikh et al., 2015

N/A

MCMV (IE1) primer/probe set Probe FAM
TCTCTTGCCCCGTCCTGAAAACC

IDT Custom PrimeTime Probe
Parikh et al., 2015

N/A

Flowjo 10.7.1

Flowjo

https://www.flowjo.com/solutions/flowjo/
downloads

ImmGen

Heng et al., 2008

https://www.immgen.org

Oligonucleotides

Software and algorithms
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Metascape

Zhou et al., 2019

http://metascape.org

Prism 9

Graphpad

N/A

QuantStudios3

Thermofisher

Cat# A28136

Seurat 3.0 for R

Stuart et al., 2019

https://satijalab.org/seurat/

RESOURCE AVAILABILITY
Lead contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Megan
Cooper (cooper_m@wustl.edu).
Materials availability
This study did not generate new unique reagents.
Data and code availability
The single cell RNA sequencing data generated during this study is available at Gene Expression Omnibus with accession number
GSE149659.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
All animal studies were performed at Washington University using an Animal Studies Committee (ASC) approved protocol and conducted in accordance with ASC regulations. All mice were maintained in specific pathogen-free conditions in group housing, bred inhouse, used between 8-14 weeks of age, and euthanized in accordance with institutional guidelines. Mice with tamoxifen-inducible
Ncr1-specific Cre expression, Ncr1-iCreERT2, were recently published (Wagner et al., 2020). Transgenic Ncr1-Cre mice with constitutive Ncr1-driven Cre were previously published (Eckelhart et al., 2011), and used for experiments shown in supplemental figures.
Mice with Cre-inducible Cox10 deletion (JAX 024697) (Diaz et al., 2005) and YFP reporter (JAX 006148) (Srinivas et al., 2001), were
purchased from Jackson Laboratories. Mice were bred to generate either tamoxifen-inducible or constitutive deletion of Cox10,
referred to here as Ncr1-Cox10D/D or cNcr1-Cox10D/D respectively. Control mice with tamoxifen-inducible or constitutive Ncr1driven Cre also crossed to YFP-reporter mice were used for all experiments. Some experiments were performed with congenic
CD45.1+ mice. B6.BXD8 mice were previously described and obtained from W. Yokoyama (Cheng et al., 2008). All mice were on
the C57BL/6 background. For Cre induction, mice were fed 250 mg/kg tamoxifen-containing Teklad chow (Envigo) which gives a
daily dose of 40 mg/kg. Both sexes were used, and sex-matched to Ncr1-Cre (Ncr1-WT) controls for experiments.
Cell lines
Ba/F3-m157 cells [from W. Yokoyama, (Smith et al., 2002)] were cultured in R10 supplemented with puromycin for selection of m157
expression and 5% IL-3- containing supernatant from X63 cells. YAC1 cells (CVCL_2244, ATCC TIB-160) were grown in R10. All cells
were kept in a 37 C 5% CO2 incubators.
METHOD DETAILS
Cell culture
Primary splenocytes from mice were cultured in ‘‘R10’’ RPMI 1640 (Mediatech) supplemented with 10% FBS (Sigma-Aldrich),
L-glutamine to a final concentration of 4 mM (Sigma), 50 mM 2-ME (Sigma), and antibiotics (penicillin/streptomycin).
NK purification
Murine NK cells were first enriched from spleens by negative selection (EasySep, StemCell Technologies) and then FACS-purified by
sorting cells based on CD3-NK1.1+ with or without YFP as indicated (FACSAria Fusion sorter, BD).
Flow cytometry
A live/dead stain was included to measure viability (Zombie Yellow, BioLegend). Cells were blocked with anti-FcgRIII (2.4G2) prior to
surface staining. Cells were fixed with 1% paraformaldehyde for surface analysis or fixed with Cytofix/Cytoperm (BD Bioscience) for
intracellular staining. For intranuclear staining, cells were fixed in Cytofix/Cytoperm and Cytoperm Plus buffer (BD) and DNase
treated. For phospho mTOR staining, cells were fixed with 2% paraformaldehyde and permeabilized with methanol. For phospho
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AMPK staining, cells were fixed with Cytofix/Cytoperm (BD Bioscience), and stained overnight at 4C with anti-pAMPK. Data was acquired on a Cytek-modified FACScan (BD and Cytek) or LSRFortessa (BD); data was analyzed using FlowJo 7.6.5. Geometric mean
fluorescence intensity and % proliferated were calculated using FlowJo proliferation analysis (see below). The following fluorochrome-conjugated antibodies were used: BrdU (BrdU kit, BD), CD107a (1D4B, BD), CD3ε (145-2C11, BD/BioLegend), CD11b
(M1/70, BD), CD226/DNAM-1 (10E5, BioLegend), CD27 (LG.3A10, BD), CD45.1 (A20 Biolegend), anti-human IFN-g (XMG1.2, BioLegend), Ly49C/I (5E6, BD), Ly49H (3D10, BD/BioLegend), NK1.1 (PK136, BD), NKG2A/C/E (20d5, BD), NKG2D (CX5, Biolegend),
NKp46 (29A1.4, BD), pAMPKa, (40H9, Cell Signaling), and pMTOR (MRRBY, Invitrogen).
NK cell functional assays
To assess intracellular IFN-g production splenocytes were stimulated with 10 ng/ml murine IL-12 (PeproTech) and 50 ng/mL
murine IL-15 (StemCell), 10ng/mL of IL-12 and 50ng/mL of murine IL-18, or in plates coated with 20 mg/ml purified antiLy49H (with or without 10ng/mL of IL-15), anti-NK1.1 (PK136; BioXcell) or control antibody for a total of 6 hours. Brefeldin A
was added to cells after 1h of culture and intracellular IFN-g production was assayed by flow cytometry using BD Cytofix/Cytoperm (BD Biosciences). CD107a degranulation assays and killing assays were performed with splenocytes incubated with
YAC-1 target cells at E:T ratios of 10:1 or 25:1 (splenocytes:target) in a 96 well round bottom plate as previously described
(Keppel et al., 2013). For killing assays, cells were incubated with 7-aminoactinomycin D (7AAD, Calbiochem) after 4 hours
of co-culture. CD107a was stained by incubating splenocytes with anti-CD107a (1D4B, BD) and GolgiStop (monensin, BD)
for 4 hours at 37 C. For analysis of IFN-g production, proliferation, and CD107a, NK cells (CD3-NK1.1+) were gated on YFP+
cells to identify NK cells with Cre activity.
Cox10 quantitative PCR
Enriched NK cells were sorted for YFP expression, and RNA was extracted using the RNA Easy kit (QIAGEN) according to the manufacturer’s protocol. cDNA from RNA was reverse transcribed using random hexamers (Promega). Both Cox10 primer/probe and
Beta-actin primer/probe set was from ThermoFisher. Fold change was calculated using the 2^-DDCt method normalized to YFPNK cells from Ncr1-Cox10D/D mice.
Extracellular flux assays
FACS-purified YFP+ NK cells were cultured with 1000 IU/mL of murine IL-2 for 72hrs. Extracellular flux assays were performed using a
XF96 Analyzer (Seahorse Bioscience/Agilent) as previously described (Keppel et al., 2015). Cell were washed and plated 4 3 105 cells
per well on poly-L-lysine-coated plates in at least triplicate for extracellular flux analysis of oxygen consumption rate (OCR) and extracellular acidification rate (ECAR). Mitochondrial stress tests were performed in non-buffered, phenol red-free RPMI media with
glucose, L-glutamine, sodium pyruvate, and 1% FBS (pH 7.4). Drug concentrations during the assay were: 10 mM oligomycin,
10 mM FCCP, 10 mM rotenone, and 10 mM antimycin A.
Cox10 activity assay
Cytochrome C Oxidase (COX) activity was measured using the Cytochrome C Oxidase Assay Kit (Sigma Aldrich). NK cells were
sorted for YFP expression, and cell pellets were snap-frozen at 80 C in 1-2 3 105 cells/vial. Samples were thawed on ice and
incubated for 30-45 minutes in 20 mL enzyme dilution buffer (10 mM Tris-HCl, 250 mM Sucrose, 1 mM N-dodecyl-b-D-maltoside,
pH = 7), then mixed with 200 mL assay buffer (10 mM Tris-HCl, 120 mM KCl). Cytochrome c was dissolved in molecular-grade H2O
at 2.7 mg/mL and reduced in a final concentration of 2 mM dithiothreitol (DTT) for 2 hours at room temperature. 20 mL of reduced
cytochrome c solution was added to the sample. Absorbance at 550 nm (A500 nm) was measured in a 96-well plate every minute
for 10 minutes with intermittent shaking on a Biotek Gen5 Microplate Reader. Control samples of Assay Buffer only, fully reduced
cytochrome c, and fully oxidized cytochrome c were also measured. COX activity was determined by the slope of the DA550 nm
from minute 0 to minute 10.
MCMV infection
8-12 week old mice were injected intraperitoneally (i.p.) with 0.5 3 104 - 2 3 105 PFU of Smith strain salivary gland MCMV (ATCC,
prepared in BALB/c mice), or media as a control. To assess proliferation during MCMV infection, mice were injected with 2 mg
BrdU (Sigma) i.p. 3 hours before harvest. For memory experiments with constitutive Cre mice, 20-30 3 106 splenocytes from
cNcr1-Cox10D/D and WT-Cox10D/D littermates were adoptively transferred by tail vein injection at a 1:1 ratio into Ly49H-deficient
Bxd8 mice. For competitive expansion/memory experiments with inducible Cre mice, YFP+ FACS-purified NK cells from CD45.2+
Ncr1- Cox10D=D and CD45.1+ Ncr1-WT mice were mixed and 1-2 3 105 cells transferred into Ly49H-deficient mice (B6.BXD8).
Male recipients were infected with 2.5 3 103 PFU MCMV 18-24 hours post transfer. Females were infected with 2.0 3 103 PFU
MCMV. Ly49H+ expansion was tracked through bleeding from the cheek vein once per week for 4 weeks. On day 28, spleen
and blood were harvested. MCMV copy number was measured as previously described (Mah et al., 2017). The limit of detection
was 100 copies of MCMV, and all values below 100 were rounded up. Graphs represent [(copies MCMV ie1)/(copies Actb)] x 1000.
Statistics were performed on log-transformed data.
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Proliferation assays
For IL-15-induced proliferation, splenocytes were stained with 2.5-5 mM Tag-it/CellTrace Violet (Biolegend) and cultured with either
5-10ng/ml (low-dose) or 100ng/mL (high-dose) murine IL-15 for 72hrs. Cells were analyzed for proliferation by CTV using FlowJo Proliferation platform (see below).
For homeostatic proliferation, NK cells were sorted for YFP expression from CD45.2+ Ncr1-Cox10D/D and CD45.1+ Ncr1-Cre YFPreporter mice (1-2 3 105 cells per mouse) and labeled with Tag-it/CellTrace Violet (CTV). They were mixed 1:1 and adoptively transferred by tail vein injection into congenic CD45.2+Rag-2/gc/ hosts and the spleens were harvested 3 and 5 days later. The ratio of
transferred cells was calculated as %recovered/%inputed, e.g. % of NK cells that were CD45.1+ NK cells in spleen/% of CD45.1+ NK
cells injected.
For Ba/F3-m157 assays, splenocytes were labeled with CTV and cultured in 20ng/mL murine IL-15 for two days, followed by addition of Ba/F3-m157 cells at a 10:1 splenocyte:Ba/F3-m157 ratio with fresh 20ng/mL IL-15 in the media for three additional days. Cells
were analyzed for proliferation by CTV using FlowJo Proliferation platform.
Proliferation using the FlowJo platform was assessed by identifying and setting an undivided peak for all samples from the same
experiment (generation 0 peak). Percentage of divided cells was calculated based on this gate. Following assignment of proliferating
cells to different generations, the following measurements of proliferative capacity of dividing cells were determined in FlowJo and
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eration number and Ni is the number of cells per generation I (Roederer, 2011).
Single-cell RNA sequencing and analysis
YFP+ NK cells were sorted from MCMV-infected mice at day 4 for single cell RNA-seq (10X Chromium platform, Illumina Hi-Seq).
Sequencing was performed by the McDonnell Genomics Institute at Washington University in St. Louis. Raw FASTQ files were
aligned to the mm10 reference using CellRanger (v3.1.0) count algorithm, and the barcode and UMI count files were aggregated
and normalized using CellRanger (v.3.1.0) aggr default options (Zheng et al., 2017). Quality control and analysis of the matrix file
was performed using Seurat V3 software for R (Stuart et al., 2019). Cells that expressed less than 200 genes and cells that expressed
more than 10% of mitochondrial associated genes were removed, remaining a total of 46,129 cells and 19,436 genes across all
samples.
Comparative analysis was done by performing an integrated analysis on all cells using Seurat software. For cluster visualization,
data was scaled and the RunUMAP tool was used to map cells, using a PCA reduction with 20 principal components. Differentially
regulated genes for each cluster and comparison between samples were determined using the FindMarkers function. Heatmaps
were made using the Heatmap function. Cell cycle analysis was performed using CellCycleScoring in the Seurat package using
genes from Nestorowa et al. (2016) and Tirosh et al. (2016). Pathway analysis was performed using Metascape (Zhou et al.,
2019). Only genes with adjusted p value < 0.05 were retained for pathway analysis. Cell identity analysis was performed using the
Immunological Genome Project (ImmGen)’s My Geneset tool with ultra-low input (ULI) RNA-Seq data (Heng et al., 2008). ScRNASeq data is available at the Gene Expression Omnibus with accession number GSE149659.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis
Statistical details of experiments can be found in figure legends. ‘‘n’’ represents number of experimental replicates and/or number of
animals in an experiment. Numbers of independent experiments performed are in the figure legends. Statistics calculated in Prism 9
with specific tests discussed in figure legends and p values noted in the figure or legend. All treatment groups used in an experiment
were included in the ANOVA analysis, including controls. For MCMV copy number, t tests were performed on log-transformed data.
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